Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PIOGLITAZONE HYDROCHLORIDE USP, with a corresponding US DMF Number 23278.
Remarkably, this DMF maintains an Active status since its submission on November 16, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 19, 2014, and payment made on February 21, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II